Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues
作者： Martin Widschwendter
DOI:
关键词:
摘要: The present invention relates to prognostic and diagnostic markers for cell proliferative disorders of the breast tissues. therefore provides methods nucleic acids analysis biological samples features associated with development disorders. Furthermore, prognosis treatment effects relating drug therapy, in particular hormonal/antihormonal chemotherapy and/or adjuvant therapy.
lens.org 参考文章(13)
Cindy Eads, Peter Laird, Epigenetic sequences for esophageal adenocarcinoma ,(2001)
William C. Dooley, Saraswati Sukumar, Ella Evron, Mary Jo Fackler, Nicoletta Sacchi, Nancy Davidson, Aberrantly Methylated Genes as Markers of Breast Malignancy ,(2002)
Gangning Liang, Peter A. Jones, Hualin Fu, Isabel D.C. Markl, Yoshitaka Tomigahara, Jonathan Cheng, Methylation altered DNA sequences as markers associated with human cancer ,(2010)
Andreas Widschwendter, Martin Widschwendter, Georg Goebel, Heidi Fiegl, Hannes M Müller, Lennart Ivarsson, Elisabeth Perkmann, Christian Marth, DNA Methylation in Serum of Breast Cancer Patients: An Independent Prognostic Marker Cancer Research. ,vol. 63, pp. 7641- 7645 ,(2003)
Andrzej Sledziewski, Kurt Berlin, Method and device for determination of tissue specificity of free floating dna in bodily fluids ,(2003)
Fritz F. Parl, Edward Gabrielson, Nancy E. Davidson, Jeremy R. Graff, Jeremy R. Graff, James G. Herman, Sharyl J. Nass, Philip W. Iversen, Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. Cancer Research. ,vol. 60, pp. 4346- 4348 ,(2000)
Timothy H.C. Hsiau, Yu Wei Leu, Farahnaz Rahmatpanah, Pearlly S. Yan, Andrew H.A. Hsiau, Joseph C. Liu, Huidong Shi, Tim Hui Ming Huang, Differential Distribution of DNA Methylation within the RASSF1A CpG Island in Breast Cancer Cancer Research. ,vol. 63, pp. 6178- 6186 ,(2003)
Stephen B. Baylin, James G. Herman, Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids ,(1997)
Angelo Agathanggelou, Sofia Honorio, Donia P Macartney, Alonso Martinez, Ashraf Dallol, Janet Rader, Paul Fullwood, Anita Chauhan, Rosemary Walker, Jacqueline A Shaw, Shigeto Hosoe, Michael I Lerman, John D Minna, Eamonn R Maher, Farida Latif, Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene. ,vol. 20, pp. 1509- 1518 ,(2001) , 10.1038/SJ.ONC.1204175
D.L. Manning, R.A. McClelland, J.M.W. Gee, C.M.W. Chan, C.D. Green, R.W. Blamey, R.I. Nicholson, The role of four oestrogen-responsive genes, pLIV1, pS2, pSYD3 and pSYD8, in predicting responsiveness to endocrine therapy in primary breast cancer European Journal of Cancer. ,vol. 29, pp. 1462- 1468 ,(1993) , 10.1016/0959-8049(93)90021-7